HDV iShares Core High Dividend ETF
Profitability Metrics
Valuation Metrics
Growth & Cash Flow
Price Change
Top 10 Holdings
| Stock Ticker | Weight |
|---|---|
| XOM | 9.51% |
| CVX | 7.16% |
| JNJ | 6.06% |
| ABBV | 5.50% |
| PG | 4.42% |
| MRK | 4.21% |
| PM | 4.21% |
| HD | 4.06% |
| PGR | 3.81% |
| KO | 3.78% |
ETF Analysis
Fund Overview
iShares Core High Dividend ETF (HDV) currently reports 75 stock positions (subject to change), placing it in the balanced in breadth range by holdings breadth. The top line-up is XOM (9.51%), CVX (7.16%), JNJ (6.06%), with XOM as the largest single weight at 9.51%. Together, the top three holdings account for 22.73%, which reflects a construction where the top positions carry meaningful but not outsized influence on aggregate returns. In aggregate, the construction reflects a balance between directional conviction and the diversification benefits that come from a broader holding set.
Profitability & Capital Efficiency
On the question of capital productivity, ROIC is 17.62%, WACC is 6.49%, and the economic spread is 11.13%. On balance, the economic spread is positive and meaningful, suggesting the underlying holdings are building rather than eroding intrinsic value. Supporting metrics show ROE at 36.03% and ROA at 8.91%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.
Valuation
From a market pricing perspective, trailing P/E of 21.72, forward P/E of 17.64, PEG of 2.54. With trailing and forward P/E closely aligned, the market appears to be pricing the portfolio on the assumption that earnings remain broadly stable near term. On a growth-adjusted basis, the portfolio carries a premium valuation relative to its growth rate. The portfolio carries an aggregate current ratio of 1.17, pointing to constrained near-term balance sheet coverage. The overall valuation picture is one where the market is paying for a specific earnings and growth outcome — and where any deviation from that path would likely pressure multiples.
Margins & Cash Generation
The margin stack reads as follows: gross margin sits at 51.91%, operating margin at 25.62%, and free cash flow margin at 16.91%. The gross margin reading points to holdings with solid but not outsized pricing power relative to direct costs. The portfolio's operating margins are solid, pointing to holdings where overhead management is a relative strength. FCF margins are constructive here, reflecting holdings that generate cash reliably after reinvestment requirements. The margin profile across gross, operating, and free cash flow levels is consistently strong — a rare combination that typically indicates durable business quality.
Growth & Forward Outlook
The forward view combines two signals: the estimated 12-month price change of 8.50%, where analyst estimates suggest only incremental upside absent a positive surprise, while TTM revenue growth of 6.43% suggesting the portfolio's holdings are growing revenues at a measured, sustainable pace. The projected 12-month EPS growth rate of 23.1% is a standout component of the forward case — meaningful earnings expansion at this scale typically warrants attention from growth-oriented investors. One metric reflects operational reality, the other market expectation — both are useful inputs, but neither should be read in isolation. The interaction between revenue execution and analyst repricing will ultimately determine how closely realized returns track current expectations. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.
Conclusion
BuyThe overall evidence base is constructive, with more signals pointing up than down and no obvious structural impairment to the forward case.
This assessment reflects quantitative metrics only and does not constitute financial advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.